Hello, Fool! | Login | Signup | My Fool
Aug 20, 2008 3:20 PM ET | Site Changes | Help
The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.
View Ticker Page (BIIB)
Results 41 - 50 of 77 : 12345Next »
Recs
cuin103 (66.86) Submitted: 4/05/08 7:27 PM : Start Price: $64.00 BIIB Score: -8.20
Bio tech play that needs consolidation
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
SuperStocker1 (26.46) Submitted: 8/14/08 9:25 PM : Start Price: $54.86 BIIB Score: 0.25
Recovery breakout upwards
KingPortu (65.15) Submitted: 10/29/07 2:36 PM : Start Price: $74.07 BIIB Score: 10.04
Not much to look at. Negative earnings, neg FCF, balance sheet is mediocre... Biotech sucks lately. What happened?
WilliamCrook2003 (68.67) Submitted: 1/28/07 6:16 PM : Start Price: $47.43 BIIB Score: 23.84
PROFIT
mf2006 (33.52) Submitted: 1/23/07 9:37 PM : Start Price: $49.26 BIIB Score: 20.13
I think the oral multiple sclerosis, if it is approved, could be a blockbuster.
dymwit (92.36) Submitted: 1/03/07 12:47 PM : Start Price: $49.98 BIIB Score: 18.64
year of biotech...
CKinRichmond (24.94) Submitted: 12/01/06 12:32 AM : Start Price: $52.50 BIIB Score: -11.87
Democrats are gunning for drug-makers and oil companies.
SoMch2Knw (51.65) Submitted: 11/26/06 3:08 PM : Start Price: $51.14 BIIB Score: 14.37
The FDA wasn't so nice this year and biotech took a beating, but the risk/reward from here looks better than the 'benchmark'.
Report this Post Replies: 1 | Reply | Permalink
chrisccarlson (77.60) Submitted: 11/03/06 10:13 PM : Start Price: $48.01 BIIB Score: 19.55
If you like biotech this is your bluechip
rowder (< 20) Submitted: 10/19/06 6:43 PM : Start Price: $45.89 BIIB Score: 24.19
Tysabi will carry them up.